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 Policies that criminalize individuals who use drugs were first enacted for the purpose of 
imposing deviant identities on impoverished and racialized communities. These policies, which 
are disproportionately enforced, have serious social, economic, and public health implications. 
Harm reduction philosophies seek to alleviate these consequences, but access to such 
programming is impeded by the stigma, enforcement, and professionalization of service 
provision associated with repressive drug policies. The failed War on Drugs is in opposition to 
harm reduction principles, thus exacerbating the harms of drug use in addition to generating 
unique harms of its own.  In order to achieve justice for the drug using community, the 
mobilization of drug policy reform advocacy at all levels is necessary. In order to contextualize 
the stigma faced by individuals who use drugs, this report will illustrate the social construction of 
drug use as immoral and subsequent labelling of people who use drugs as deviant in an 
examination of the historical context of drug prohibitions and harm reduction philosophies. In 
highlighting the empirical evidence in support of harm reduction programming, I identify gaps in 
service provision and assess the ways in which prohibitory drug policies act as a barrier to 
service delivery, and in conclusion, provide recommendations for policy reform and means for 
achieving structural change. 
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Policies that criminalize individuals who use drugs were first enacted for the purpose of 
imposing deviant identities on impoverished and racialized communities. These policies, which 
are disproportionately enforced, have serious social, economic, and public health implications. 
Harm reduction philosophies seek to alleviate these consequences, but access to such 
programming is impeded by the stigma, enforcement, and professionalization of service 
provision associated with repressive drug policies. The failed War on Drugs is in opposition to 
harm reduction principles, thus exacerbating the harms of drug use in addition to generating 
unique harms of its own.  In order to achieve justice for the drug using community, the 
mobilization of drug policy reform advocacy at all levels is necessary. 
The rationale for the present literature review is threefold; first, to systematically review 
Canadian harm reduction programming and thus identify gaps in existing services; second, to 
compare and contrast harm reduction and criminalization based philosophies, assessing their 
ability to coexist, and; third, to provide program and policy recommendations for exacting 
changes in drug policy and programming in-line with best-practices. In short, I seek to provide a 
comprehensive analysis of the current climate in Canada regarding substance use, and direction 
for growth. 
In order to contextualize the stigma faced by individuals who use drugs, this report will 
illustrate the social construction of drug use as immoral and subsequent labelling of people who 
use drugs as deviant in an examination of the historical context of drug prohibitions and harm 
reduction philosophies. Utilizing interpretive theories of crime to assess the phenomenon of drug 
use and subsequent criminalization of people who use drugs, I examine these processes through a 
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critical lens that accounts for the impact of stigma throughout the development of North 
American drug laws. In doing so, I discuss the progression of these laws over the course of a 
century, and the consequences of such.     
The efficacy of harm reduction programs as internationally recognized best practices in 
addressing drug use in society will be reviewed. A presentation and assessment of the principles 
and philosophies of harm reduction as a whole is provided, in addition to discussion of various 
established categories of harm reduction programming (e.g. needle exchange programs, 
supervised consumption sites, opioid substitution therapy).  In the wake of the current opioid 
overdose epidemic in North America, I review how this surge of drug-related deaths has 
impacted Canadian harm reduction policies and programming, and vice-versa.  This is 
particularly pertinent in regards to recent innovations in harm reduction programming. My 
evaluation of Canadian harm reduction programming lends itself to the identification of gaps in 
service provision, particularly in regards to target populations (e.g. students, prisoners, the 
homeless, party-goers), in addition to recent innovations in harm reduction programming, such 
as the expansion of supervised consumption sites, the development of drug checking programs, 
and the increasing accessibility of naloxone distribution programs. 
In highlighting both the empirical evidence in support of harm reduction programming, 
and the gaps in service provision, I assess the ways in which prohibitory drug policies act as a 
barrier to service delivery. Assessing the success of harm reduction programs in improving 
public health will provide context for the detrimental impacts of drug prohibition, and its 
position as being ideologically opposed to harm reduction programming.  Examining the harms 
of criminalization and elaborating on how stigma generated by drug policies, the enforcement of 
these policies, and the resulting professionalization of service provision, are situated as barriers 
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to service delivery, demonstrates a clear conflict between harm reduction and criminalization 
ideologies, and, by extension, this constructs a foundation on which arguments for policy reform 
may rest.  Therefore, I provide recommendations both for policy reform, and means for 
achieving structural change. A presentation of the Portuguese model of decriminalization then 
serves as an example of alternate drug policies, supplemented by a discussion regarding the 
legalization and regulation of various illicit substances, and recommendations regarding social 
movements as a means for achieving policy reform. 
Harm reduction programming began in North America in the 1980’s as a grassroots 
movement, led by individuals who use drugs, to tackle the HIV epidemic in their communities. 
Now, despite its recognized efficacy and role in Canada’s four pillar-approach to addressing 
substance use, innovations in Canada’s harm reduction programs to address the opioid overdose 
epidemic are again being achieved via the leadership of people with lived experience. Despite 
decades of research, and little argument amongst scholars regarding the harms of prohibition and 
the benefits of harm reduction programming, real change has always occurred at the hands of 
these social movements.  In order to achieve justice for the drug using community, the 
mobilization of drug policy reform advocacy at all levels is necessary, with a primacy for 
respecting the leadership and experiences of these communities.   
The criminalization of drug use is an injustice to people who use drugs, exasperating the 
harms of substance use, generating harms of its own, and acting as an impediment to health and 
social services. This philosophical conflict between principles of harm reduction and the 
prohibition of drug use necessitates consideration of alternative policy frameworks for 
addressing drug use in society that seek to eliminate the stigma associated with substance use. 
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Historical Construction of Drug Use as Deviant 
Although policies regulating substance use are ever-changing, they have been 
omnipresent in Canada for over a century.  Since the beginning of the 1900’s, a variety of drug 
prohibitions have been implemented, many of which still exist today.  Since their inception, drug 
laws have served the primary objective of criminalizing the use of various substances, and 
consequently, the populations they are most commonly used by. Understanding the inequitable 
and racialized manner in which the criminalization of drug use was conceptualized and enforced 
(i.e. the historical construction of drug use as a criminal, and therefore deviant or immoral 
offence), is pivotal in creating a theoretical framework by which the arguments contained herein 
are supported.  
As non-European populations began to settle in Canada in the early twentieth century, the 
existing populace perceived immigrants as a threat to the moral order of white hegemony. As a 
result, sensationalist attitudes regarding immigrant culture became prevalent, while cultural 
differences were quickly constructed as deviant (Gordon, 2009; Mena & Hobbs, 2009). 
Subsequently, policies were enacted to criminalize ethnic minorities, the earliest of which was 
the country’s first prohibitory drug policy. The first of many drug prohibitions, the passing of the 
Opium Act of 1908 represented the initial construction of the “deviant drug user”. Since then, 
repressive drug policies have proven to be an effective tool for criminalizing impoverished and 
racialized communities, with prohibition serving as a means of propagating systemic racism 
(Musto, 1991; Provine, 2011; Zong & Perry, 2011).  This Opium Act characterized the earliest 
construction of drug use as a crime, and consequently, an act of deviance. For over a century, 
people who use drugs in Canada have been labelled as deviants and criminals, and have faced 
enormous stigma. 
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 A once highly contested topic, there is now very little argument that the “war on drugs” 
has been largely unsuccessful in eradicating drug use, as promised upon its commencement in 
the 1970s under the Nixon administration (Wodak, 2014). Research now points to the many 
ways drug prohibition has exacerbated the harms associated with drug use, and created new ones 
of its own.  To combat the injuries associated with drug use and zero-tolerance drug laws, harm 
reduction programs were first implemented in the 1980s during the HIV pandemic (Campbell & 
Shaw, 2008). However, these programs have not been prioritized by the state, which still places 
emphasis on the enforcement of drug prohibition. Therefore, the criminalization of people who 
use drugs exists as an impediment to harm reduction services (Drucker, 2013).  This disregard 
for the wellbeing of individuals who use drugs is the result of labelling people who use drugs as 
deviant, and reflects an injustice to the drug using community.  
Theoretical Framework 
Interpretive Theories of Crime 
Largely interested in utilizing the scientific method to determine cause and effect, 
positivist theories of crime seek to objectively understand why people engage in criminal 
activities (Bereska, 2014). Interpretive criminological theories, on the other hand, are subjective 
views of deviance that believe in the societal construction of deviance. From this perspective, it 
is understood that we are incapable of identifying deviant behaviour without being informed by 
social and legal norms what we should consider to be deviant. Interpretive theories are more 
symbolic, originating from an understanding that our social realities are created by our 
interactions with the world around us. Critical theories are also in contrast to positivism, focusing 
on dynamics of power and how this power plays into the construction of social and legal norms. 
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Together, interpretive approaches, such as labelling theory, and critical approaches, such as 
conflict theory, constitute a social constructionist perspective to understanding deviance. 
Critical theories are also in contrast to positivism, focusing on dynamics of power and 
how this power plays into the construction of social and legal norms. They are largely value-
oriented, and self-reflective, with a particular focus on social justice. While interpretive theories 
are easily tested, measuring the validity of critical theories is more challenging, as they are not a 
“shared body of propositions, generalizations, and supporting evidence”, but an “intellectual 
posture around which a variety of criminological endeavours have been pursued” (Akers, Sellers, 
& Jennings, 2014, pp. 250).  In other words, critical theories are about applying critical analysis 
to criminological work by examining structural and institutional inequalities and contextualizing 
deviance and social problems (McLaughlin & Muncie, 2013). Together, interpretive approaches 
and critical approaches constitute a social constructionist perspective to understanding deviance. 
A prominent interpretive approach, labelling theory, and one of the earliest critical approaches, 
conflict theory, are amalgamated herein as a social constructionist approach to understanding 
deviancy.  
Conflict Theory. Conflict theorists argue that our socially constructed legal rules and 
social norms arise not from consensus of the masses, but from conflict. These rules serve to 
benefit society’s most powerful groups, who are less likely to disobey such rules as they were 
created to serve their interests. The behaviours of those in society with less power are 
criminalized by these legal and social rules, as their creation serves to define the acts of the 
disenfranchised as deviant. Those with power imposed these rules on less powerful groups in 
society, who come into conflict with the law due to their experiences of oppression.  Although 
there are many forms of conflict theory, its origins are traced to Karl Marx, who believed that 
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those with the greatest power in society own the means of production, and the less powerful 
include the working class, who sell their labour to the powerful. Those who come into conflict 
with the law do so as a result of the alienation they experience in this respect, due to factors such 
as poor working conditions.  
In modern times, power is assessed by variables such as age, race, class, gender, 
sexuality, and ability, with race and class perhaps being the most prominent. In other words, 
racialized communities and individuals of low socio-economic status are understood as the 
“powerless”, as these variables are what best reflects power and authority in modern society 
(McLaughlin & Muncie, 2013). It is for this reason that conflict theorist’s contest that 
impoverished and racialized peoples are overrepresented in Western criminal justice systems.  
Labelling Theory. Labelling theories discuss the process of being assigned a deviant 
label and the consequences of such. By this perspective, the assignment of a deviant label results 
in differential treatment and eventual adoption of this label as one’s identity. Without the 
imposition of a deviant label, individuals may eventually transition out of the so-called deviant 
behaviour on their own. However, when one engages in particular deviant acts, our 
understanding of that person becomes primarily about that particular act. In other words, once 
one breaks various social or legal rules, we understand them as deviants, and nothing else. Once 
one is labelled as a deviant, it may become part of their identity, for which there are serious 
social ramifications. Those identified as deviants undergo experiences of social exclusion and 
stigmatization, which carry with them serious consequences (Bereska, 2014; Dotter, 2002; 
Goffman, 1974).   
Stigma. According to Goffman (1974), the stigmatization of an individual is the social 
reaction to one’s possession of an attribute that is widely viewed as undesirable or deviant.  In 
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this sense, stigmatization is the consequence of the social construction and labelling of 
difference.  Largely based on stereotypes, stigma stems from assumptions made about particular 
differences or traits that are viewed as undesirable by the majority, and thus characterized as 
deviant (Goffman, 1974; Link & Phelan, 2006). The greater society perceives the stigmatized 
attribute as a personal failing of the individual who possesses it, and as a result, individuals 
internalize this stigma and begin to view themselves as inferior. Individuals experience 
discrimination and victimization as a result of the stigma arising from their deviant labels, 
resulting in social exclusion and isolation (Goffman, 1974; Link & Phelan, 2006; Smith, 2009). 
The identity of an individual outside of their stigmatized trait is largely ignored, and thus, they 
become defined by their deviant label. Consequently, the social construction of difference and 
subsequent labelling of individuals as deviant cause stigmatization, the casting of individuals to 
the margins of society, and the compounding of consequences of their experience of difference.  
Social Constructionism. Labelling and conflict theories together, constitute social 
constructionist theories of deviance, focusing on subjective understandings of deviant behaviour 
and the processes by which social problems are defined as such. Social constructionism seeks to 
understand how various social issues and deviant behaviours are defined, established, and 
reacted to (Bereska, 2014; Rafter, 1990). One way of responding to social problems is by the 
assignment of deviant labels that are created and assigned based on social and legal rules. 
Deviance may be explained as a socially constructed concept, validated by law, which serves to 
enhance conformity and reaffirm the social solidarity of “non-deviant” members of society. As 
various societal structures and systems complement one another to ensure the orderly functioning 
of society, “threats” to social order are regulated, and thus dictate to the public which actions are 
considered to be deviant.  By doing so, the perceived “moral rightness” of non-deviant members 
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of society is augmented via the stigmatization of non-conforming individuals (Bereska, 2014; 
Ziyanak & Williams, 2014). Therefore, deviance is not about the qualities of an individual, but 
the social reaction to those who engage in behaviour that run counter to these social norms 
(Akers et al., 2014; Dotter, 2002). These rules, and subsequent labels, are created by those in 
positions of power and imposed on those with lesser social capital. Therefore, it may be 
understood that deviant labels are the result of a lack of power (Akers et al., 2014). 
This social construction of difference exists in many aspects of identity; for example, the 
construction of drug use as deviant is directly related to the same phenomenon in regards to race 
and class. Early drug laws served the function of demonizing marginalized populations, and are 
known to be disproportionately enforced to this day (Fellner, 2009). Drug prohibitions have a 
long history of constructing moral panics around minorities and drug use, and imposing deviant 
labels on people who use drugs. As a crime of morality, drug use is not a deviant act in and of 
itself; drug use is considered to be deviant because it is illegal.  The criminalization of drug use 
serves to increase social solidarity among those who do not use illicit substances by creating a 
morality of health (Bereska, 2014; Farrugia, 2014). This is accomplished by stigmatizing 
individuals who use drugs, inevitably leading to an atmosphere of cynicism towards the drug 
using community, who are subsequently labelled as deviants. As a result, the drug using 
community faces enormous stigma, based on stereotypes of people who use drugs as immoral, 
negligent, and generally inept. Consequently, people who use drugs are perceived as inferior and 
undeserving of the same opportunities accessed by non-users (Goffman, 1974). This perception 
of drug use engenders social exclusion and isolation, and can result in their internalizing of their 
“deviant drug user” label, thus exacerbating the social, physical, and legal detriments of their 
drug use (Link & Phelan, 2006; Smith, 2009). Because drug use is criminalized, those who use 
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drugs are stigmatized not only as “drug users”, but as criminals. The stigma of the criminal label 
negatively impacts an individual’s ability to gain meaningful employment, reduces educative 
opportunities, and lessens the likelihood that one will form various pro-social bonds (Apel, 
Blokland, Nieuwbeerta, & van Schellen, 2009; Windzio, 2006). Additionally, because those who 
experience marginalization, such as racialized and impoverished communities, are more likely to 
be criminalized for their substance use, this stigma is compounded for already disenfranchised 
populations (Fellner, 2009). 
 The stigma and discrimination faced by people who use illicit-drugs acts also as a barrier 
in accessing support services, education, treatment, and medical/social services that seek to 
ameliorate the harms associated with drug use (Edington & Bayer, 2013). As a result, it has been 
hypothesized that the prohibition of drug consumption and associated stigmatization of people 
who use drugs is, in and of itself, responsible for thousands of preventable overdose deaths in 
North American each year (Drucker, 2013).  The stigma associated with drug use results in the 
labelling of those who use drugs as undesirable and, in turn, unworthy of health care. 
Subsequently, there is a general reluctance to approve the implementation of harm reduction 
programs (Farrugia, 2014; Mena & Hobbs, 2009).  Due to the “not in my backyard” mentality, 
many communities prohibit the provision of these services. When services are implemented, they 
are scarcely funded, and hostility, pessimism, and malpractice run rampant amongst social 
workers and health care providers (Edington & Bayer, 2013). Consequently, the stigma that 
exists as a result of repressive drug policies results in people who use drugs having limited 
access to medical care that is rooted in evidence. When the stigma of substance use is alleviated, 
individuals are more likely to utilize harm reduction programing that may lessen the harms 
associated with their drug use (Lacquer, 2015). 
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Drug prohibition has been highly criticised for its exceptionally high economic and social 
costs, and ineffectiveness at reducing the availability of illicit substances (Drucker, 2013; 
Rhodes, 2011). Drug prohibition has been accused of criminalizing society’s most 
disenfranchised communities. Individuals of low socio-economic status, immigrants, and ethnic 
minorities are targeted by enforcement, thus exacerbating a variety of already omnipresent social 
inequalities (Fellner, 2009; Gordon, 2009; Provine, 2011). By criminalizing people who use 
drugs, the deviant label and subsequent stigmatization is unavoidable.  However, by reframing 
drug use as a public health concern instead of a criminal justice issue, this label may be revoked. 
Although the detrimental impacts of the criminalization of drug use cannot be eliminated without 
full drug policy reform, harm reduction initiatives exist to alleviate some of the harms of drug 
use and zero-tolerance drug policies. 
  





The History and Efficacy of Harm Reduction Philosophies 
Harm reduction refers to any policy, program, or initiative that seeks to minimize the 
risks that are associated with drug use and/or zero-tolerance drug policies (Lushin & Anastas, 
2011; McKeagany, 2011).  The focus of these initiatives are primarily on adverse health effects, 
but also often address social and economic consequences of drug use and drug policy (Grieve, 
2009; Rhodes, 2011). Pragmatic in its approach, harm reduction philosophies manifest as person-
centred, public health approaches to addressing the impact of drug use on individuals and 
communities. This is achieved by utilizing a stance of non-judgement to accept people as they 
are in terms of their drug use, socio-economic status, and ability (Campbell & Shaw, 2008; 
Lushin & Anastas, 2011).  In other words, harm reduction programs operate with a respect for 
individual experience and do not typically require the sobriety of the individuals accessing their 
services. This creates an environment in which individual identity is appreciated, and those who 
use drugs are understood both within, and outside of the context of their drug use. These 
programs seek to reframe the way people who use drugs are viewed by society by discounting 
their deviant labels. This erosion of stigma and empowerment of service users is associated with 
a number of positive outcomes for those who utilize harm reduction programs (Campbell & 
Shaw, 2008; McKeagany, 2011; Rhodes, 2011).  
 Harm reduction initiatives originated at the hands of people who inject drugs during 
height of the HIV epidemic in the 1980s, at a time when gay men, ethnic minorities (primarily 
Haitians), and people who use drugs were scapegoated for the spread of HIV. By the late 1980s, 
governments were well aware of the efficacy of harm reduction programs, yet refused to fund 
these programs out of concern for appearing to condone the use of illicit substances (Friedman et 
DRUG CRIMINALIZATION VS. HARM REDUCTION 
13 
 
al., 2001).  In response to this lack of government intervention, people who inject drugs engaged 
in collective action to combat the stigmatization and lack of public health approaches to dealing 
with drug use, and by the late 1990s, harm reduction initiatives and drug users’ alliances existed 
in over forty countries world-wide (Friedman et al., 2001). As a result of this collective action, 
gains have been made in many arenas of drug policy and service delivery in Canada. Common 
harm reduction initiatives include honest education, needle exchange programs (NEPs), 
supervised consumption sites (SCSs), and opioid substitution therapy (OST). However, in the 
past decade, harm reduction programming has expanded to include onsite drug checking 
services, safer inhalation and intranasal drug use material distribution, and naloxone 
administration training and distribution programs (NATDPs). Additionally, the efficacy of 
supervised consumption sites has been validated by the Supreme Court of Canada, and in 
Toronto, the first ever harm reduction workers’ union is fighting to combat the 
professionalization of their field of work (Bazazi, Zaller, Fu, & Rich, 2010; McCann & 
Temenos, 2015; Piper et al., 2007; Schroers, 2002). Harm reduction programs are still scarcely 
funded, but the attention paid to these programs by governments across the globe has increased 
drastically since their advent (Edington & Bayer, 2013). 
Harm reduction initiatives are now internationally recognized by health care 
professionals and policy experts as a best practice in minimizing the consequences of drug use 
within society (Drucker, 2013; Edington & Bayer, 2013; Eversman, 2014; McKeagany, 2011; 
Rhodes, 2011). Steeped in empirical evidence, harm reduction approaches are both cost-
effective, and renowned for their ability to reduce a myriad of consequences of drug use, 
including blood borne illness, infection, and the social isolation that is a result of the stigma that 
people who use drugs face.  Additionally, harm reduction programs are successful in improving 
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both medication adherence, and the mental health of service users (Campbell & Shaw, 2008; 
Drucker, 2013; Edington & Bayer, 2013; Lushin & Anastas, 2011; Rhodes, 2011). By promoting 
dignity and compassion, harm reduction programming integrates individuals who use drugs into 
the greater community; this represents a stark contrast to traditional tendencies towards 
dehumanizing and isolating the drug using community (McKeagany, 2011).  As a result, these 
programs celebrate greater efficacy rates than abstinence-based approaches, which are associated 
with high post-treatment relapse and overdose rates.  It is for these reasons that harm reduction 
has been prioritized in national HIV strategies in dozens of countries across the globe (Edington 
& Bayer, 2013; McKeagany, 2011).   
Harm reduction exists in Canada as part of a four pillar approach to addressing drug use, 
alongside prevention, enforcement, and treatment. Common harm reduction initiatives include 
honest education, needle exchange programs (NEPs), supervised consumption sites (SCSs), and 
opioid substitution therapy (OST).  Additionally, recent developments in harm reduction 
programming, such as naloxone administration training and distribution programs (NATDPs), 
and on-site drug checking (OSDC) are becoming more prevalent in the western world in 
response to the recent opioid overdose epidemic (Cicero, 2017; Young & Fairbairn; 2018). 
Honest Education  
 Honest education is a primary tenet of harm reduction approaches to drug use. This 
approach to drug education exists to counter zero tolerance, preventative approaches used in the 
public school system, such as Racing Against Drugs or Drug Abuse Resistance Education 
(DARE). These preventative approaches are referred to as “drug education”, although they 
typically involve the use of fear tactics in an attempt to eliminate drug use, and very little 
information regarding the realities of substance use is provided. These abstinence-based 
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“education” programs construct a morality of health that stigmatizes individuals who use drugs 
and privileges those who abstain (Farrugia, 2014).  Educative approaches that provide health 
directives to reduce drug use related harm are referred to as “honest education” to distinguish 
them from traditional approaches to drug education (Grieve, 2009; Strang et al., 2002). These 
approaches are rarely utilized in public school drug education, but are an essential component of 
harm reduction services. Honest approaches to drug education are utilized with the 
understanding that minimizing the harm associated with drug use is best accomplished by 
providing individuals with necessary information for them to make informed decisions regarding 
their physical and mental health (Farrugia, 2014; McBride, Farringdon, Midford, Mueleners, & 
Phillips, 2004). According to Farrugia (2014) and McBride et al. (2004), harm reduction 
approaches to drug education have greater success in reducing substance use than traditional 
programs. Additionally, honest education increases safer-consumption behaviours, thus reducing 
the harms associated with substance use, such as overdose and the contraction of blood-borne 
illness (Farrugia, 2014; McBride et al, 2004).  
Needle Exchange Programs (NEPs) 
 Needle exchange programs (NEPs) are the most extensively utilized of harm reduction 
services. Existing in over twenty countries worldwide, endorsed by the World Health 
Organization and UNAIDS, and widely recognized as a fundamental component of any effective 
HIV prevention strategy (Edington & Bayer, 2013; Hurley, Jolley, & Kaldor, 1997; McKeagany, 
2011; Zule et al., 2018). NEPs are known, primarily, for providing individuals who use drugs 
intravenously with access to sterile needles. Although each facility is unique, these programs 
generally provide a plethora of materials to reduce the risks associated with injection drug use 
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(e.g. alcohol swabs, ascorbic acid, cooking spoons, filters, syringes, sterile water, and 
tourniquets).  
While not as common, some facilities also provide materials used for non-injection routes 
of drug administration (Domanico & Malta, 2012; Drucker, 2013; Ivsins, Roth, Nakamura, 
Krajden & Fischer, 2011; Patterson et al., 2018).  Although there is a growing understanding of 
best practices in offering services for individuals who engage in injection drug use, there is less 
acknowledgement of harm reduction techniques targeting inhalation drug use, particularly with 
crack-cocaine. The risks of crack-cocaine smoking, such as infection, blood-borne disease, and 
overdose, are often just as prevalent as those associated with injection drug use, and in some 
instances, more so, as is the case with Hepatitis C infection, and the two populations tend to 
overlap (Ivsins et al., 2011; Patterson et al., 2018). Many of the dangers associated with 
inhalation drug use are largely related to the use of unsafe equipment, or sharing materials, and 
there is evidence for both the willingness of individuals who smoke crack to utilize programs 
that distribute safer-use materials, and of the efficacy of these programs in reducing the sharing 
of materials and use of makeshift equipment (Cortina et al., 2018; Domanico & Malta, 2012; 
Ivsins et al., 2011). Pyrex stems, brass screens, rubber mouthpieces, push sticks, and lip balm are 
offered to service-users who, despite an awareness of the risks, would likely see no other choice 
but to utilize more hazardous means to smoke crack-cocaine. Despite legislative barriers, these 
programs have purported efficacy in reducing injury, infection, disease, and participation in the 
illegal economy, in addition to increasing client’s health awareness and perceived 
personal/community safety. A growing support for safer inhalation services is building in 
Canada (Domanico & Malta, 2012; Ivsins et al., 2011). 
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Regardless of the materials distributed, NEPs typically offer counselling and support 
services, educational resources and referrals to medical, social, and treatment services. As the 
most highly researched harm reduction program, dozens of studies have confirmed the 
effectiveness of NEPs; they have shown to maximize the health and safety of individuals who 
use drugs, reduce social marginalization, and decrease global rates of blood borne illness, 
infection, and drug overdose (Campbell & Shaw, 2008; Bowring et al., 2013; Hurley et al., 1997; 
Rhodes, 2011; Striker & Miskovic, 2018). Empirical evidence also demonstrates that these cost-
effective services reduce health care costs associated with the treatment of medical conditions 
linked to drug use (Drucker, 2013).  
Supervised Consumption Sites (SCSs) 
Like NEPs, supervised consumption sites (SCSs) offer honest education and equipment 
to reduce the risks associated with drug use, in addition to access to primary health care services, 
counselling, referrals to withdrawal and rehabilitation programs, and housing opportunities. 
(Tyndall et al., 2005; Wood et al., 2004). However, SCSs also provide private cubicles for 
injection and/or inhalation drug use, as well as a social space used to monitor and connect with 
service users, and administer medical care in the event of an overdose.   
 Unlike NEPs, SCSs have historically been seldom implemented and scarcely funded. 
Until recently, there were under one-hundred facilities located worldwide, with only one of these 
sites operating within North America.  This facility, located in Vancouver, British Columbia, has 
been vigorously studied since its doors were opened as a controversial pilot project in 2003 
(Bayoumi & Zaric, 2008; McCann & Temenos, 2015; Tyndall et al., 2005; Wood et al., 2004).  
This SCS, referred to as Insite, remained a pilot project for eight years, until its value was 
eventually proven in the Supreme Court of Canada in 2011 (Kerr, Mitra, Kennedy, & McNeil, 
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2017; McCann & Temenos, 2015).  Since then, the empirical evidence of Insite’s efficacy has 
inspired talks of program expansion, and by 2018, in response to the growing opioid overdose 
crisis, Health Canada confirmed dozens of projects across four Canadian provinces, and many 
other in various application stages (Cicero, 2017; Health Canada, 2018; Young & Fairbairn, 
2018). 
 A stark increase in opioid overdose deaths was declared a public health emergency in the 
United States in the fall of 2017, and despite a staggering death toll of it’s own, Canada had yet 
to do so by the end of 2018 (Bestha, 2018). The crisis has been attributed to an overprescribing 
of opioids by physicians and surgeons, and the recent emergence of more potent opioids, such as 
fentanyl and carfentanil, mixed into other street drugs without buyer knowledge, in order to 
increase drug potency (Cicero, 2017; Guevremony, Barnes, & Haupt, 2018; Makary, 2017; 
Vadivelu, Kai, Kodomundi, Sramcik, & Kaye, 2018; Volkow & Collins, 2017). As the opioid 
epidemic grew to claim tens of thousands of lives each year in North America, victims were no 
longer solely those belonging to society’s most marginalized communities. As white, middle-
class, suburban communities saw death tolls rise, the government and media alike began to take 
note of the epidemic (Cicero, 2017; James & Jordan, 2018; Vadivelu et al., 2018).  Mainstream 
recognition of the opioid overdose crisis is largely credited to the advocacy work of grassroots 
organizations such as the Vancouver Area Network of Drug Users (VANDU). Much like the 
harm reduction advocacy work done during the height of HIV epidemic, people who use drugs 
have headed these movements through acts of civil disobedience, creating pop-up SCSs without 
permit or Health Canada sanction, in major Canadian cities, such as Victoria and Ottawa. 
Despite heavy police presence, minimal funding, and no legislative support, these volunteer run 
pop-sites offer services to thousands of clients and report no fatal overdoses on their premises 
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(Cicero, 2017; Kerr et al., 201; Young & Fairbairn, 2018). By the end of 2017, after much 
resistance, the city of Ottawa responded to a local pop-up site by opening a formal SCS and 
accelerating the approval of several more sites. Now, dozens of sites in several provinces across 
the country have been approved, with applications processing for dozens more. However, even in 
the midst of an overdose crisis, legislative barriers make these sites difficult to establish – 
especially those that are facilitated by people who use drugs (Cicero, 2017; Health Canada, 2018; 
Kerr et al., 2017).  
Fifteen years after opening its doors, there have been over 40 peer reviewed studies on 
the beneficial impacts of Insite, and the lack of negative outcomes. With over three million visits 
and over five thousand overdoses, Canada’s SCS has yet to see a single fatal overdose (Cicero, 
2017; Young & Fairbairn, 2018). Insite now offers drug-testing services in order to attempt 
combat the overdose epidemic; although 80% of drugs tested at the facility tested positive for 
fentanyl, clients typically alter their consumption habits to accommodate for the presence of the 
potent drug, resulting in a reduction of fentanyl related overdoses (Young & Fairbairn, 2018).  It 
is now widely understood that the presence of SCSs reduces public drug consumption and drug-
use related litter, the sharing and make-shifting of materials and therefore the spread of 
infections and disease, overdose fatalities, participation in illegal economy, and stigma, in 
addition to increasing safer use and disposal practices, and access to treatment services, whilst 
remaining cost-effective and relieving financial burdens of drug-use on public health care and 
criminal justice systems, and without increasing the frequency of substance use. (Bayoumi & 
Zaric, 2008; Folch et al., 2018; Young & Fairbairn, 2018; Voon et al., 2016).   
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Naloxone Administration Training and Distribution Programs (NATPDs) 
Naloxone is an opioid antagonist, meaning it is a medication that has the ability to halt 
the effects of opioids, and is especially useful in overdose situations (Bazazi et al., 2010; Piper et 
al., 2007). In the event of opioid overdose, an injection of Naloxone can reverse the effects of the 
drug taken (i.e. heroin, fentanyl) and therefore revive the individual experiencing overdose.  This 
medication has long been used by health care professionals and emergency response units, but 
more recently has become accessible to the public (Piper et al., 2007). Naloxone administration 
training and distribution programs (NATDPs) are a more recent development in the sphere of 
harm reduction programming. In the wake of the opioid overdose crises, these programs dispense 
naloxone kits primarily to individuals at risk of opioid overdose, but increasingly, to family and 
friends of those who use opioids, and other members of the community (Bazazi et al., 2010; 
Lewis, Park, Vail, Sine, & Welsh, 2016).  Many programs require that individuals take an 
administration training course to ensure they are well informed with regards to the procedures for 
administering the medication before obtaining naloxone (Bazazi et al., 2010; Lewis et al., 2016; 
Piper et al., 2007). Due to the criminalization of non-prescribed opioid use, individuals are often 
hesitant to access emergency services when witnessing an opioid overdose, and with many 
Canadian provinces seeing dozens of overdose deaths each week, health care resources are 
spread thin. Thus, NATDPs allow bystanders to respond to overdose situations without fear of 
police or need for medical professional involvement. NATDPs have shown to reduce drug-
related mortality, in addition to increasing overdose awareness amongst individuals who use 
opioids and their peers (Curtis et al., 2018; Petterson & Madah-Amiri, 2017; Piper et al., 2007).  
Opioid Substitution Therapy (OST) 
Opioid substitution therapy (OST) is perhaps the most controversial of harm reduction 
programs.  This medical intervention substitutes the use of illegal opioids and/or misuse of 
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prescription painkillers with methadone or buprenorphine, which have higher half-lives and 
therefore remain in the body for longer periods of time (Drucker, 2013). This means that these 
substances need to be consumed less frequently in order to avoid withdrawal, than other opioids. 
These substitutions have significantly less psychoactive effects, allowing for higher functioning 
than the drug which they substitute for.  Opioid withdrawal syndrome at its worst may last 
several months, and have the potential to be deadly if not medically supervised. By preventing 
the occurrence of withdrawal symptoms, patients of OST may avoid this lengthy and hazardous 
detoxification period, and instead incrementally reduce their methadone or buprenorphine 
dosages. Additionally, these substances are consumed orally, which is a safer route of 
administration than the common method of intravenous drug use (Strang et al., 2002). OST is 
known to reduce adverse health effects of opioid use, such as overdose and blood-borne illness, 
in addition to reducing drug-related offending (Edington & Bayer, 2013; Rhodes, 2011; 
McKeagany, 2011). OST is rooted in empirical evidence, and when compared to abstinence 
based drug treatment programs, is more likely to result in eventual abstinence from opioid use. 
Unfortunately legislative restrictions and stigma often make these programs difficult to access 
(Guevremony et al., 2018). More recently, in response to the overprescribing of opioids, 
researchers and advocates have begun to consider alternative mechanisms for managing chronic 
pain, such as the substitution of opioid prescriptions with cannabis (Lucas, 2017; Volkow & 
Collins, 2017). 
In addition to saving lives and reducing the harms associated with substance use, the 
aforementioned harm reduction programs place an emphasis on respect for individuals who use 
drugs. Therefore, they work to counteract the stigmatizing effects of criminalization by 
constructing a new frame of reference for understanding drug use as a social reality, instead of a 
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deviant act. By doing so, harm reduction rejects the deviant label so often placed upon people 
who use drugs by upholding principles that value individual health and safety. However, due to 
this ideological difference, the criminalization of drug use conflicts with harm reduction 
principles and serves as an impediment to service delivery. 
Gaps in Service Provision 
As harm reduction garnishes widespread support and is invoked as a principle tool for 
tackling the opioid overdose crisis, some populations fall to the wayside. As a result of the 
continued emphasis on enforcement over harm reduction when addressing substance use related 
concerns, and the stigma associated with criminalization, the potential for harm reduction 
programs falls short of what is necessary. Despite strides made in the funding of NEPs, and new 
legislative support for SCSs, the very services these programs offer are unavailable to large sub-
groups of the drug-using population. The following section provides overview of four main areas 
which demonstrate deficits in harm reduction service provision: music festivals and night clubs 
(i.e. party drugs), college and university students/campuses, homeless communities (particularly, 
youth), and prisons.  
Party Drugs  
Party drugs, typically stimulants, are drugs used in a recreational context, generally at 
music related events, such as festivals and night clubs.  Individuals using party drugs do not 
generally identify as having an addiction, nor do they tend to use drugs on a daily basis. 
Additionally, this recreational drug use involves utilizing routes of administration unlike those 
aforementioned (i.e. snorting, swallowing).  As there are marked differences in the consumption 
of party drugs in comparison to that of heroin or crack-cocaine, there are also differences in harm 
reduction service provision for individuals who use these substances.   
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Harm reduction materials for these alternative routes of administration are scarcely 
provided via NEPs, and are generally addressed in the context of recreational or party drug use. 
Some similarities, however, do exist; drug checking, although more commonly utilized in SCSs, 
is a technique also used to reduce drug related risks at music festivals and nightclubs hosting 
raves (Hungerbuehler, Buecheli, & Schaub, 2011; Schroers, 2002).  This service involves the on-
site testing of various illicit substances to determine their content and purity.  While the 
aforementioned harm reduction services are most often utilized by individuals with addictions to 
illicit substances, this sort of drug checking is a harm reduction tactic that targets recreational 
users. These music related events are most frequently attended by youth, who are more 
commonly engaging in regular recreational drug use on these occasions  (Whittingham et al, 
2009).  Because their use is considered recreational, individuals who use party drugs generally 
limit their use to these events, and do not use drugs on a daily basis. As a result, they do not 
access substance use services, which are typically facilitated under an addictions framework, and 
are relatively difficult to locate without attending events at which party drugs are used.  
Therefore drug checking services are often facilitated by networks of individuals who actively 
use recreational drugs (Frei, 2010). 
Stimulants, such as a cocaine or amphetamines (predominately ecstasy/MDMA) are 
commonly used party drugs (Panagopoulos & Ricciardelli, 2005; Whittingham et al., 2009). 
Drug checking services are vital to the reduction of risk associated with the use of party drugs.  
Because these substances are obtained via the black market, users cannot be sure of the contents 
or dosages or the drug they are consuming, putting them at an increased risk of overdose and/or 
consequences of dangerous synergistic effects (Schroers, 2002). On-site drug checking services 
also provide other basic harm reduction services, such as honest education, information 
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regarding trends in the illegal drug market, and materials associated with reducing harms related 
with the party scene (Frei, 2010). Examples of these materials include condoms, water, ear plugs, 
and intranasal drug use materials (e.g. straws, alcohol swabs, sterile water, and vitamin E 
capsules). Additionally, many of these services also offer counselling, consultations, and 
referrals to social and health care services (Hungerbuehler et al., 2011). Despite the prevalence 
of polysubstance use at these events, due to the illegal nature of commonly used party drugs, on-
site drug checking faces many barriers in implementation (Fernandez-Calderon, Diaz-Batanero, 
Barratt, & Palamar, 2018). These services often involve the transfer of illicit substances from 
service users to service providers, which constitutes an illegal act (Schroers, 2002). This means 
that both parties are at risk of criminalization, resulting in reluctance to provide and access 
services, in addition to event venues being hesitant in allowing the provision of these services on 
their properties (Mohr, 2018).  
Due to the risk involved in providing these services, nightlife harm reduction is often self 
or peer directed. Organizations such as the Toronto Rave Information Program (TRIP) and 
DanceSafe operate solely on a volunteer basis, using the lived experience and knowledge of 
individuals who use drugs to disseminate harm reduction knowledge where traditional, 
preventative approaches have failed (Greenspan, Aguinaldo, Husbands, Murray, & Ho, 2011; 
Mohr, 2018; Whittingham et al., 2009). Peers offer information on rationing and dosages, 
“coming down” (i.e. withdrawal), and support for individuals experiencing “bad trips” or 
unenjoyable highs. Although peer-led harm reduction programming in the music scene is 
beginning to gain support, harm reduction for party-goers is still considered controversial, and 
has historically been excluded from harm reduction research (Greenspan et al., 2011; 
Whittingham et al., 2009). However, over the past five years, an emergence of a literature on the 
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potential of harm reduction programs at raves and music festivals has developed, as pressure for 
the implementation of these programs builds alongside the opioid overdose crisis (Fernandez-
Calderon, et al., 2018; Mohr, 2018; Young, Diedrich, Pirie, Lund, Turris, & Bowles, 2015).  
College and University Campuses 
College and university students use a variety of drugs, both legal and illicit, and campus 
drug use is on an incline. The university environment one of risk, both in its physical spaces (i.e. 
dormitories), and in its social norms (i.e. party culture) (Abelman, 2017; Wilkinson & Ivsins, 
2017). Alcohol consumption and the practice of binge drinking is more than common place in 
these environments; it is considered a normative part of the college or university experience. 
With the increase in young people engaging in recreational drug use, party culture on campuses 
is no longer limited to dangerous alcohol consumption, but the use of party drugs as well 
(Whittingham et al., 2009). In addition to alcohol and recreational illicit substance use, post-
secondary students make up a sub-group of individuals who use drugs that is almost solely 
restricted to the university campus; those who use “study drugs”. Study drugs are medications 
typically prescribed for the treatment of attention deficit disorders, used by college and 
university students to increase focus and elongate working hours (Abelman, 2017).  These three 
avenues of drug use places college and university students at an increased risk of substance-use 
related harms, yet harm reduction programming is not commonplace in these environments, and 
when they do exist, they almost solely target alcohol consumption. Additionally, many campuses 
have policies in place that impose academic penalties on students who are determined to have 
engaged in on-campus substance use (Abelman, 2017; Wilkinson & Ivsins, 2017) 
Harm reduction information regarding sexual activity and alcohol consumption have 
become commonplace in the education of college and university aged students, and in some 
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regions, amongst high school aged students as well. Studies have found positive results in the use 
of alcohol harm reduction education in both high school and college/university settings, with a 
reduction in frequency and quantity of alcohol consumption noted in both groups (McBride et 
al., 2004; Bersamin, Mallie, Fearnow-Kenney, & Wyrick, 2007). In fact, the Nova Scotia 
Department of Health and Wellness (2012) endorses harm reduction practices in addressing 
alcohol related harms on campus, and Queens University in Ontario has both staff and students 
involved in alcohol harm reduction education and outreach. Despite the understanding of harm 
reduction as a best practice in reducing alcohol related risks on campuses, this knowledge has not 
translated to other areas of risk faced by college and university students, such as the use of 
recreational party drugs, or study drugs. Because of the dynamic nature of college and university 
student substance use, and the multiple avenues of drug use on which a student may embark, it is 
particularly important that campus harm reduction programming take a unique approach that 
addresses the individual needs of each campus community. As is often the case with 
programming geared towards young people, harm reduction services on campus must reflect the 
needs and experiences of the communities in which they exist (Jenkins, Selmon, & Haines-Saah; 
2017). 
Homeless Communities 
Homelessness itself presents challenges to controlling the spread of blood-borne ailments 
and sexually transmitted infections, making homeless communities an important primary target 
for interventions (Clatts & Davis, 1999). Homeless individuals are at high risk for contracting 
blood-borne ailments and sexually transmitted infections, with homeless youth at highest risk, 
largely due to their participation in the street economy (Carmona, Slesnick, Guo, Murnan, & 
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Brakenhoff, 2017; Clatts & Davis, 1999; Coren et al., 2013; Hwang, Wilkins, Tjepkema, 
O’Campo, & Dunn, 2009).  
Despite the wide support for harm reduction programming, homeless youth are still 
contracting blood-borne ailments at alarming rates (Clatts & Davis, 1999). Equipped with the 
understanding that homeless youth are one of the most difficult to reach populations, it may be 
speculated that this these youth are not accessing life-saving programming in their communities 
(Carmona et al., 2017; MacDonald, 2014).  Harm reduction programming has amassed known 
proficiency in reducing the harms associated with high-risk behaviour, reducing the transmission 
of blood-borne ailments and sexually transmitted infections, and attracting youth to accessing 
services, yet this is not reflected in the rates of transmission among homeless youth (McDonald, 
2014; Strang et al., 2012; Werb et al., 2010).  Current research calls for investment in outreach 
programming as a vital means of connecting with homeless youth in particular, as many avoid 
attending shelters and drop-in centres, and do not interact with the criminal justice system 
(Carmona et al., 2017; Clatts & Davis, 1999; MacDonald, 2014). Outreach programming is also 
often more proficient in responding to trends in risk-taking behaviours and factors influencing 
the transmission of blood-borne ailments and sexually transmitted infections that differ in 
varying locales (Werb et al., 2010). The need for programming that is grounded in local research, 
which respects the dynamic nature of this population is emphasized (Carmona et al., 2017; Clatts 
& Davis, 1999; Coren et al., 2013; Hwang et al., 2009; Werb et al., 2010). 
Young people without stable housing are at heightened risk of contracting blood-borne 
ailments and sexually transmitted infections. Despite harm reduction programming being 
globally recognized as best practice in reducing these risks, homeless youth are still contracting 
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ailments and infections at increased rates. Due to the hidden nature of this population, we must 
consider whether harm reduction programs are being accessed by those who need them. 
Prisons 
 Prisons are potentially one of the most controversial of sites for implementing harm 
reduction programming, despite the heightened substance-use related risk that inmates and 
former inmates face (Curtis et al., 2017; ;Petterson & Madah-Amiri, 2017). While some harm 
reduction philosophies and practices are present in Canadian prisons, they generally target the 
promotion of safer sex and tattooing practices, and do not include NEPs (Reece, Van der 
Meulen, & Ka Hon Chu, 2018; Van der Meulen, 2017).  In fact, of the 15 initiatives set forth by 
the United Nations Office on Drugs and Crime, including counselling, education, addictions 
programs, and OSTs, NEPs are the only one excluded in Corrections Services Canada’s policies 
and programming (Smith & de Souza, 2018). Despite the success of prison NEPs in other 
countries worldwide, there is much opposition to the implementation of similar programs in 
Canadian facilities (Reece et al., 2018; Van der Meulen, 2017).  Like much of the hostility 
towards harm reduction programming, this is largely based in a lack of understanding of harm 
reduction philosophies and a belief that providing these services acts to encourage substance use 
and threatens the safety of the surrounding community. Contrastingly, NEPs in prisons are 
known to improve workplace safety for corrections workers; in fact, prison staff were the most 
adamant critics of the abolition of prison NEPs in Germany in recent years (Reece et al., 2018). 
This indicates a dire need for training amongst corrections staff in regards to best practices in 
reducing harm in prisons. 
 Despite myths and misunderstanding, injection drug use does indeed occur inside 
correctional facilities. Without the availability of NEPs, the equipment needed for injection drug 
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use is either gained illicitly or made by inmates, is often shared, and is unlikely to be safely 
disposed of, despite prisoner willingness to engage in harm reduction practices (Curtis et al., 
2018; Petterson & Madah-Amiri, 2017, Van der Meulen, 2017).  Furthermore, harm reduction 
training is especially important for this population, who are at increased risk of drug-related 
harms upon release from prison. Seemingly decades behind the harm reduction movement 
occurring outside prison walls, prisons do not offer the same level of health care to inmates who 
use drugs as those in the community receive (Van der Meulen, 2017; Van der Meulen, De Shalit, 
& Ka Hon Chu, 2017). 
 Harm reduction has garnished widespread support since its induction some fifty years 
ago. Once an entirely grassroots movement, headed by people with lived experience in substance 
use, a variety of harm reduction programs are provided by dozens of organizations across the 
provinces of Canada. These efficacy of these programs, some government-funded, some peer-
based, have grossed significant empirical evidence and have been invoked as a best practice in 
addressing both the HIV/AIDS epidemic of the 70s and the more recent opioid overdose crisis in 
North America. Supervised consumption sites, needle exchange programs, opioid substitution 
therapy, drug-checking, and naloxone distribution are beginning to shed their stigma, with 
networks of people who use drugs at the forefront of an ever growing movement.  However, 
many populations remain unable to access these life-saving services, many of which remain 
controversial, with advocates forced to engage in civil disobedience in attempts to remove the 
barriers to harm reduction programing put in place by Canada’s drug policies.  
  





The Conflict between Harm Reduction and Criminalization 
Harm reduction is now well known to be a best practice in addressing substance use 
concerns. However, these programs are supported by philosophies of non-judgement, 
compassion, and acceptance, and do not actively condemn people who use drugs. In a country 
where drug use is focused on through a criminal justice lens, harm reduction operates 
ideologically opposed by the dominant systems of prohibition and enforcement. As 
aforementioned, not only does the criminalization of drug us have historical roots as a means of 
oppression of immigrant or otherwise “undesirable” populations, it hinders harm reduction 
programming by engraining stigma and “not in my backyard” mentalities, instilling fear and 
hostility in community members, property owners, and health care practitioners. As a result, 
programs are underfunded, with outreach programming scarce, and prisons, university campuses, 
and music venues hesitant to allow harm reduction services on their premises. Following a brief 
overview of current Canadian drug laws, this section will review in-depth three ways in which 
the criminalization of drug use acts as a barrier to implementing harm reduction programming; 
by breeding hostility in law enforcement, stigma in the community, and progressing the 
professionalization of harm reduction service provision. 
The Current Canadian Context 
In 1987 a four-pillar approach consisting of prevention, harm reduction, treatment, and 
enforcement tactics for addressing drug use was integrated into the Controlled Drugs and 
Substances Act of Canada (CDSA). However, the CDSA, like the policies that proceed it, places 
emphasis on the pillar of enforcement.  The CDSA introduced stiffer penalties than those found 
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in the prior Narcotic Control Act, allowing the police to charge and prosecute a greater number 
of drug offenders (Gordon, 2009; Riley & Nolan, 1998).  Legislation like the CDSA illustrates 
that despite a supposed four pillar approach to drug use, Canada still views drug use as a criminal 
justice issue, as opposed to a public health concern, and in doing so, creates massive barriers in 
service provision (Campbell & Shaw, 2008).  Despite the proven efficacy of harm reduction 
programs, they are most effective when implemented in combination with the decriminalization 
of drug use (Drucker, 2013; Eversman, 2014). Because criminalization involves the labelling of 
people who use drugs as deviants and the construction of drug use as immoral, it ideologically 
conflicts with the principles of harm reduction, which seeks to address drug use in a non-
judgemental and compassionate manner. Not only do prohibitory drug policies fail to prevent 
drug use and its associated harms, they exacerbate these harms, and create new ones (Campbell 
& Shaw, 2008; Drucker, 2013; Eversman, 2014).  The continued criminalization of drug use 
serves to impede access to harm reduction services by creating a climate of hostility from police, 
stigma from the public, and a professionalization of service provision (Drucker, 2013; Edington 
& Bayer, 2013). 
Criminalization as an Impediment to Service Delivery 
Stigma. As a crime of morality, drug use is not a deviant act in and of itself; drug use is 
considered to be deviant because it is illegal.  The criminalization of drug use serves to increase 
social solidarity among those who do not use illicit substances by creating a morality of health 
(Bereska, 2014; Farrugia, 2014). This is accomplished by stigmatizing individuals who use 
drugs, inevitably leading to an atmosphere of cynicism towards the drug using community, who 
are subsequently labelled as deviants. As a result, the drug using community faces enormous 
stigma, based on stereotypes of people who use drugs as immoral, negligent, and generally inept. 
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Consequently, people who use drugs are perceived as inferior and undeserving of the same 
opportunities accessed by non-users (Goffman, 1974). This perception of drug use engenders 
social exclusion and isolation, and can result in their internalizing of their “deviant drug user” 
label, thus exacerbating the social, physical, and legal detriments of their drug use (Link & 
Phelan, 2006; Smith, 2009). Because drug use is criminalized, those who use drugs are 
stigmatized not only as “drug users”, but as criminals. As will be expanded upon below, the 
stigma of the criminal label negatively impacts an individual’s ability to gain meaningful 
employment, reduces educative opportunities, and lessens the likelihood that one will form 
various pro-social bonds (Apel et al., 2009; Windzio, 2006). Additionally, because those who 
experience marginalization, such as racialized and impoverished communities, are more likely to 
be criminalized for their substance use, this stigma is compounded for already disenfranchised 
populations (Fellner, 2009). 
 The stigma and discrimination faced by people who use illicit-drugs acts also as a barrier 
in accessing support services, education, treatment, and medical/social services that seek to 
ameliorate the harms associated with drug use (Edington & Bayer, 2013). The stigma associated 
with drug use results in the labelling of those who use drugs as undesirable and, in turn, 
unworthy of health care. Subsequently, there is a general reluctance to approve the 
implementation of harm reduction programs (Farrugia, 2014; Mena & Hobbs, 2009).  Due to the 
“not in my backyard” mentality, many communities prohibit the provision of these services. 
When services are implemented, they are scarcely funded, and hostility, pessimism, and 
malpractice run rampant amongst social workers and health care providers (Edington & Bayer, 
2013). Consequently, the stigma that exists as a result of repressive drug policies results in 
people who use drugs having limited access to medical care that is rooted in evidence. When the 
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stigma of substance use is alleviated, individuals are more likely to utilize harm reduction 
programing that may lessen the harms associated with their drug use (Lacquer, 2015). 
Professionalization of Service Provision. Despite the proven success of harm reduction 
programming, the criminalized and subsequently stigmatized nature of drug use serves as a 
tremendous barrier in accessing these programs. Potential service users are hesitant to utilize 
harm reduction programs due to a general mistrust of service providers and a fear of prejudice. 
The stigmatization of drug use results in a general apathy among professionals in regards to the 
health and wellbeing of people who use drugs, with consequences for how services are provided.  
The hostility and discrimination that service users face when accessing harm reduction programs 
results in a reluctance to continue utilizing these services in the future (Aitken, Kerger, & Crofts, 
2009; Edington & Bayer, 2013).  This means that harm reduction programs are failing to reach 
the very people who may benefit from their services, largely due to the professionalization of 
harm reduction work.   
Harm reduction initiatives originated at the hands of people who inject drugs during the 
HIV epidemic, but have since come to exclude people who use drugs from service provision 
(Campbell & Shaw, 2008; Eversman, 2014; Marshall, Dechman, Minichiello, Alcock, & Harris, 
2015; Tookey, Mason, Broad, Behm, & Bondy, 2018).  Harm reduction programming, 
particularly NEPs, have become a specialized field of social work, employing only those with 
educational backgrounds, and disregarding the lived experience and community ties of 
individuals who have engaged in drug use. The professionalization of harm reduction work not 
only lessens the potential impact of these programs, but takes jobs away from people who use 
drugs by preferencing formal education over lived experience. Exclusionary, professionalized 
practices in the field of harm reduction prevent many people who use drugs from gaining 
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employment as harm reduction workers. Those who are able to obtain employment in harm 
reduction programs are hired as peer workers, and are often inadequately compensated, 
sometimes receiving, at most, small honorariums, as opposed to the salaries and benefit packages 
their colleagues receive (Broadhead et al., 1998; Marshall et al., 2015).  This exclusion of people 
who use drugs from service provision reinforces stereotypes of people who use drugs as 
irresponsible or incapable. Allowing for service provision by individuals who use drugs erodes 
their deviant labels and may work to counteract these stereotypes. 
The term “peer work” refers to the inclusion of people who actively use drugs in service 
provision, thus counteracting the professionalization of harm reduction work.  Peer work is 
recognized as a best practice, vital in the efficacy of harm reduction programs and practices 
(Tookey et al., 2018). Individuals who use drugs report being more likely to access services that 
are provided by people who have personal experience with drug use due to the stigma and 
cynicism that is so common among service providers (Broadhead et al., 1998; Edington & Bayer, 
2013). Peer work, then, extends the reach of harm reduction initiatives, and therefore heightens 
the known benefits of harm reduction work (Latkin, Sherman, & Knowlton, 2003; Strang et al., 
2002).  
This is particularly pertinent when it comes populations facing intersections of 
marginalization’s, such as homeless youth who use drugs. These young people, despite their 
aptitude for personal harm reduction and risk management tactics, are far less likely to seek 
support from formal services than adults who use drugs, and more often make changes in their 
lives based on their own personal experiences and those of their peers, rather than by the urging 
of parents and service providers (McDonald, 2014).  
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Peer work is also especially significant in the treatment of blood-borne ailments in people 
who inject drugs. As aforementioned, these individuals face a great deal of pessimism of behalf 
of medical service providers, thus lending itself to a sense of distrust and hopelessness that 
virtually eliminates the potential for medical treatment (Tookey et al., 2018).  Because harm 
reduction programs serve a hard-to-reach population, utilizing peer networks aids in making 
these services accessible to a greater number of people (Aitken et al., 2009; Broadhead et al., 
1998).  Furthermore, involvement in peer work allows people who use injection drugs to 
promote safety in their communities in a way that aligns with their own moralistic standpoint; 
this is understood as an unlikely opportunity without the support of a harm reduction network 
(Barnes, Des Jarlais, Wolff, Freelemyer, & Tross, 2018). 
In addition to heightening the scope of harm reduction programming, including active 
drugs users in service provision also has a positive impact on the lives of peer workers in many 
areas of their lives. By adopting helping roles in their social networks, and professional roles in 
their service provision networks, peer workers gain a sense of community, thus reducing their 
sense of social isolation. The responsibility that comes with these roles acts as an agent of 
empowerment for individuals who use drugs, allowing peer workers to gain a sense of 
confidence in a wide array of skills and experiences (Aitken et al., 2009, Latkin et al, 2003).  
Peer worker anecdotes as relayed by Tookey et al. (2018) demonstrate beneficial impacts of this 
employment experience as reaching many avenues of ones life, such as increased food and 
housing stability, reworking of social relationships, and marked changes in substance use 
practices that align with harm reduction philosophies and techniques.  
Peer work provides opportunity to narrow a significant gap in steps toward recovery; 
vocational opportunities. Engaging in education or formal employment is often understood as an 
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anticipated milestone in the process of recovery, a damaging assumption to be made without 
regard for obstacles present for people who use drugs, or have recently become sober. Peer work 
allows for the smoothing of these obstacles, by offering employment opportunities in a field in 
which personal experience with substance use may be understood as an asset. The work 
environment may then be one of mutual respect, understanding, and support, and the professional 
role one that allows for flexibility and transition time. Peer work also supports a certain level of 
fluidity between the professional and personal work of an individual who uses drugs, allowing 
their employment to act as a conduit for their own growth in terms of their harm reduction 
practices (Tookey et al., 2018). For example, compensation offered for peer work acts as 
incentive for participation in harm reduction programming, engaging in health care 
opportunities, and potentially the eventual sobriety of the worker, while acting as a reminder of 
progress throughout the recovery process.  This opportunity to give back to one’s community 
helps to alleviate the internalized stigma that individuals who use drugs often face, thus building 
confidence while acquiring legitimate work experience and transferable skills (Aitken et al., 
2009; Latkin et al., 2003; Tookey et al., 2018). 
Regardless of demographics, literature widely illustrates a desire to engage in harm 
reduction practices among individuals who use drugs (Barnes et al., 2018; Curtis et al., 2018; 
McDonald, 2014; Tookey et al., 2018). When it comes to interacting with peers in a substance-
using context, people who use drugs regulate their interactions in response to their own morals 
and understanding of harm reduction, largely with the desire to align themselves to helping 
behaviours.  Decisions to offer assistance, information, or advice to other people who use drugs 
are grounded in the individuals belief of what would best serve to protect the safety of the person 
in question. In other words, people who use drugs are already working to promote the reduction 
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of substance-use related harms in their communities (Barnes et al., 2018; Curtis et al., 2018). By 
re-evaluating the required qualifications and compensation for employment in service provision, 
and investing in people who have, or do use drugs, within a harm reduction framework, we may 
welcome them into service provision and offer a framework for these helping behaviours that is 
grounded in research (Tookey et al., 2018).  By allowing for the contributions of peer workers, 
harm reduction programs can be better informed, extend their reach, and have greater impact on 
both individuals accessing services, and those providing them. 
Enforcement. The emphasis on enforcement and subsequent criminalization of 
individuals who use drugs philosophically conflicts with harm reduction ideology, and therefore 
impedes the provision of services that have been proven to be effective in reducing the harms 
associated with drug use in society (Drucker, 2013; Eversman, 2014; Kerr, Small, & Wood, 
2005).  The criminalization of drug use forces people who use drugs into hiding while doing so; 
hiding from police also means remaining invisible to service providers and health care 
professionals. Not only does this displacement make this already hard-to-reach population 
difficult for harm reduction outreach workers to locate, it forces people who use drugs to engage 
in their substance use in isolated locations, where help may be unavailable in the case of an 
emergency, such as accidental overdose. Furthermore, strong police presence in drug using 
communities deters individuals from accessing services, interacting with outreach service 
providers, carrying harm reduction supplies, and seeking medical assistance, all due to fear of 
their substance use becoming known to law enforcement officers (Kerr et al., 2005; Marshall et 
al., 2015; Rhodes, 2011). This fear of enforcement puts people who use drugs at an increased 
risk, as they experience hesitancy in accessing emergency services while in critical situations, 
and therefore the policing of drug using communities obstructs service access.  
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The enforcement of drug policies also exacerbates the harms of drug use and creates 
additional risks (Kerr at al., 2005; Rhodes, 2011). Individuals who have had interactions with 
police regarding their substance use are more likely to engage in a myriad of high risk drug use 
behaviours. Due to a fear of police interaction and subsequent criminalization, individuals who 
inject drugs rush the process of preparing for, and engaging in intravenous drug use. For 
example, these individuals are more likely to share needles and/or neglect to clean the site of 
injection or the materials they are using. Additionally, they are less likely to do a test dose, which 
involves taking a small dose of their drug in order to test its strength and effects before 
consuming a full dose. This leaves people who inject drugs at an increased risk of infection and 
overdose (Kerr et al., 2005).  
  Individuals who do become involved in the criminal justice system due to illicit drug use 
are often impoverished, living with concurrent mental health disorders, and potentially facing a 
myriad of health concerns.  This results in further marginalization, as involvement with the 
criminal justice system brings with it even greater socio-economic consequences (Campbell & 
Shaw, 2008). Not only does the imposition of severe sanctions on individuals who use drugs do 
little to deter them from future drug use, there is a great deal of stigma associated with the 
criminal label that comes as a result of having a record of criminal charges and incarceration 
(DeFina & Hannon, 2013; Strang et al., 2002). Furthermore, because drug laws often target low-
income individuals, the incarceration of non-violent drug offenders often involves the removal of 
primary wage earners.  Even upon release from incarceration, those convicted of drug offences 
face stigma and restrictions to their liberty that may hinder their ability to obtain employment, 
and if they do, it is likely that they will earn much less than they would if they did not have a 
criminal record (Apel & Sweeten, 2010; Western, 2002). There are a number of reasons for this: 
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stereotypes associated with the criminal label, gaps in education and employment history due to 
incarceration, curfews, and geographical boundaries can all play a part in preventing the 
obtainment of legitimate employment upon release from prison (Apel & Sweeten, 2010; DeFina 
& Hannon, 2013; Western, 2002).  As racialized and impoverished communities are 
disproportionately impacted by drug laws, incarceration of drug-offenders further marginalizes 
an already disenfranchised population.  
 Living with the label of “deviant” or “criminal”, and facing difficulties accessing 
legitimate employment, are hypothesized as possibilities for the high recidivism rates associated 
with incarceration. Individuals who are charged and subsequently sentenced to a period of 
incarceration are more likely to reoffend than those who have received other sanctions. 
Additionally, incarceration does little to prevent future substance use for drug offenders. 
Therefore, the label of “deviant drug user” becomes a self-fulfilling prophecy, and only 
perpetuates a cycle of drug use, sanctions, and stigmatization (Cesaroni, 2014; Apel & Sweeten, 
2010). Strong social bonds, however, have potential to help break this cycle. Reintegration into 
the community through engagement with institutions such as education, employment, and 
marriage is known to reduce the prospect of re-offending. However, the stigma associated with a 
history of incarceration diminishes the likelihood of involvement in these institutions (Apel et 
al., 2009; Windzio, 2006). 
Repressive drug policies are said to exist with the purpose of eradicating drug use in 
society, but it widely acknowledged that they have failed in doing so, as such a society is 
unattainable (Campbell & Shaw, 2008; McKeagany, 2011). Prohibitory drug policies work to 
exacerbate the risks associated with drug use, in addition to generating new harms.  The 
criminalization of drug use is, by nature, oppositional to harm reduction programming; 
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criminalization constructs a label of deviance to be imposed on people who use drugs, whereas 
harm reduction philosophies emphasize respect and compassion for those who use drugs. 
Because of these ideological conflict, the criminalization of drug use impedes access to life 
saving services (Hurley et al., 1997; Kerr et al., 2005). Alleviating the stigma associated with 
drug use, eliminating the detrimental impacts of drug policy enforcement, and incorporating 
individuals who use drugs into service delivery must be prioritized if harm reduction services are 
to become more widely accessible (Edington & Bayer, 2013; Marshal, 2005; Strang et al., 2002).  
To achieve these goals, Canadian drug policies must be revaluated and aligned with harm 
reduction philosophies (Drucker, 2013; Rhodes, 2011).  
  





Recommendations for Policy Reform 
Armed with an understanding of the history of Canada’s drug laws, and the efficacy of 
harm reduction programming, the blockade of enforcement that stands between people who use 
drugs and the services intended to protect them is a notable concern. It has been established that 
these policies directly contribute to the stereotypes associated with people who use drugs, with a 
myriad of consequences. With SCSs and NATDPs long battle for federal approval, the 
commonality of malpractice in OSTs, and the lack of services reaching students, homeless 
communities, prison inmates, and party goers, progress in addressing substance use during an 
opioid overdose epidemic is squandered by legislative barriers and law enforcement operations. 
While harm reductionists work to shine light on a deep-seeded societal injustice, enforcement 
efforts prove counter-productive, moving people who use drugs further to the margins of society, 
creating a climate of fear around these harm reduction services. With harm reduction 
programming remaining for decades as a best practice in addressing substance use related 
concerns, drug policy must adapt to reflect harm reduction philosophies in order to truly reap it’s 
rewards – not only in the lives of people who use drugs, but in the community, and public health 
and criminal justice systems. Thus, this final section offers considerations and recommendations 
for legislative change that embodies principles of respect, dignity, and autonomy, via the 
mobilization of social movements. 
Considerations in Policy Reform 
When deliberating alternatives to repressive drug policies, we must consider how various 
policy frameworks may service the greater public good. Legal scholars have long theorized about 
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the purpose of law, and many believe that its primary goal should be to serve the best interests of 
the majority of society, and protect citizens from harm (Mill, 2010; Troyer, 2003). Due to its 
incompatibility with programs that reduce the prevalence of HIV, and the costs associated with 
health care, and the criminal justice system, the criminalization of drug use harms not only 
people who use drugs, but the greater population (Campbell & Shaw, 2008; Drucker, 2013). As 
decriminalization and the regulation of drug use in society have demonstrable ability to improve 
the lives of not only individuals who use drugs, but society as a whole, they are most likely to 
serve the public good and protect the public from harm (Lacquer, 2015; Vale de Andrade & 
Carapinha, 2010). 
In addition to considering the public good in reforming drug policies, the autonomy and 
liberty of people who use drugs is also of concern. The argument may be posed that, providing 
no harm is imposed on others, individuals should have the right to choose what they put in their 
bodies, regardless of the harms it may cause to themselves (Mill, 2010). In this sense, the 
criminalization of drug use may be understood as impeding on the liberty of people who use 
drugs. Additionally, the barriers that repressive drug policies create in accessing social and 
medical services, the negative impacts that criminalization has on individuals and communities, 
and the disproportionate manner in which drug policies are enforced on already marginalized 
members of community, may all be understood in the context of individual liberty and 
autonomy.  
Arguments for the criminalization of drug use have historically centred on moral issues 
and beliefs that condemn substance use, as opposed to focusing on the safety and liberty of 
individuals who use drugs. Criminal activities that are believed to run counter to dominant moral 
ideologies, in contrast to crimes resulting in the harm of one person by another, are referred to as 
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crimes of morality (Carpenter & Hayes, 2007; Hathaway & Mostaghim, 2015). This construction 
of morality results in the imposition of labels of deviancy and immorality upon those who 
engage in these activities. Crimes of morality, also known as victimless crimes, have been highly 
debated topics among academics, policy makers, and the general public.  The criminalization of 
prostitution and doctor-assisted suicide exist alongside repressive drug policies, sharing many 
similar harms associated with drug prohibition. The criminalization of crimes of morality result 
in detrimental circumstances for the populations they are imposed upon, forcing them to occupy 
increasingly dangerous spaces in order to conduct the prohibited activity in question, thus 
exacerbating their associated harm (Kerr et al., 2005).  
Crimes of morality are often discussed within a framework of radical non-intervention. 
Radical non-intervention calls for a reassessment of the way in which we think about criminality, 
and an understanding that the harms of criminalization far outweigh the costs (Schur, 1973). This 
involves the designation of policies that are steeped in empirical evidence, going beyond the 
rhetoric of punishment and isolation. By appreciating the ability of individuals to emerge from 
their drug use on their own terms, we may set the stage for policy frameworks that exist in a 
place of respect and dignity, thus challenging systemic inequalities (Schur, 1973; Sheldon, 
2004). By ceasing to construct those who use drugs as deviant, we may allow individuals who 
use drugs to avoid becoming identified with a “deviant drug user” label. Additionally, we may 
focus on dispensing justice for more serious crimes, and providing effective intervention 
programs. When discussing alternative policies for regulating drug use, we may look to 
discussions regarding other crimes of morality for inspiration and understanding.  
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Decriminalization: The Portuguese Model 
The regulatory framework implemented in Portugal at the turn of the twenty-first century 
provides us with policy directives for alternatives means of addressing drug use in society.  
Portugal’s national drug policy involves a complete decriminalization of all drug offences that 
are not related to trafficking.  As part of their national harm reduction strategy, all drug offences 
are addressed as administrative violations and are not processed through the traditional court 
systems (Temenos, 2016; Vale de Andrade & Carapinha, 2010; Van Het Loo et al, 2002). In 
doing so, those who use drugs are not labelled as criminals. Depending on the context of the 
violation, these individuals may be issued an oral warning, or referred to a dissuasion 
commission where they are either recommended for drug treatment, or have minor sanctions 
imposed upon them.  These sanctions may include peer and location restrictions, removal of the 
right to practice a particular profession (i.e. childcare), or periodic reports to the commission. 
Upon successful completion of a treatment program, these sanctions are removed (Lacquer, 
2015). 
Since the decriminalization of drug use in Portugal, the country has seen a one-hundred 
and fifty per cent increase in drug treatment completion, and a massive reduction in the 
prevalence of injection drug use, overdose deaths, and HIV (Vale de Andrade & Carapinha, 
2010; Van Het Loo et al., 2002). This approach has allowed medical and social services to 
individualize their programming, enabling those who use drugs to do so in a way that results in 
minimal harm to themselves and their communities, and focusing treatment efforts on those who 
are ready to cease their drug use entirely (Vale de Andrade & Carapinha, 2010).  Furthermore, 
decriminalization has alleviated the immense burden placed upon the criminal justice system 
from prosecuting minor drug offences, allowing law enforcement efforts to focus on large scale 
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drug trafficking. Although there were concerns that without deterrence through legal sanctions 
drug use would increase, since decriminalization, Portugal has possessed the lowest rates of drug 
use within the European Union and has seen an increase in access to harm reduction 
programming (Lacquer, 2015). However, Portugal continues to be criticized for its lack of 
regulation of illicit drug markets; a full legalization and regulation approach would ensure that 
drugs are safely obtainable from legitimate markets, further alleviating the harms associated with 
drug use (Van Het Loo et al., 2002). 
Legalization & Regulation  
Although decriminalization has demonstrated the ability to alleviate some of the harms of 
drug use and zero-tolerance drug policies, illicit substances are still cultivated and distributed via 
the black market (Van Het Loo et al., 2002).  This means that in order to obtain drugs, 
individuals have no choice but to interact with this illegal market and its associated dangers.  The 
illegal drug trade is known for its volatility and is associated with violence. Without government 
regulation of drug markets, these markets are often run by street gangs, and result in violence to 
establish territory, combat competition from rival gangs, and enforce debt payments (Moeller, 
2017; Naranjo, 2015; Reuter, 2009). Additionally, this lack of regulation causes market prices 
for illicit substances to fluctuate greatly (Naranjo, 2015). As providing illegal substances 
becomes more dangerous, due to the risk of criminalization, prices rise, and individuals who 
purchase drugs from the black market are unable to cope with increased costs. This results in an 
increase of crime to generate funds to purchase drugs, opening the door for numerous detriments 
associated with law-breaking, such as subsequent interactions with the criminal justice system 
(Greenberg, 2016; Moeller, 2017; Wodak, 2014). Furthermore, when one obtains illicit 
substances in the illegal market, they have no way to be sure of the contents or dosages or the 
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drug they are consuming, increasing the risk of overdose and side effects from dangerous drug 
synergies (Schroers, 2002). For these reasons, the decriminalization of drug possession and 
consumption alone is not enough to ameliorate the harms of drug use and repressive drug 
policies (Grieve, 2009).  
The term “legalization” is often mistaken for a laissez-faire approach that allows for 
unrestricted access to once illicit substances.  In reality, legalization is more synonymous with 
regulation. In contrast to decriminalization, full legalization of drug use involves government 
regulation of the cultivation and sale of drugs, much like the regulated alcohol, cannabis, and 
tobacco markets in Canada. Similarly, legalization would involve the imposition of age and 
geographical restrictions for consumption, with public intoxication and sales to minors remaining 
to be criminal offences (Steel, 2006). Substances sold under this framework may be labelled with 
health risks, as is the case with tobacco, or dosage recommendations (Mostyn, Gibbon, & 
Cowdery, 2012).  
To date, no country has implemented a comprehensive framework for regulating drug 
cultivation and distribution, and it is unlikely that a one-size-fits-all approach would be effective 
in regulating all currently illicit drugs. For example, it is improbable that a policy model for 
regulating cannabis would be recommendable for regulating the use of heroin or ecstasy. Where 
cannabis regulation may be modeled after the tobacco and alcohol markets, purchasing drugs that 
are considered to be more addictive and less likely to be used recreationally, such as heroin, may 
require proof of a diagnosed substance dependency. This type of prescription model existed in 
the United States and United Kingdom as early as the 1920’s, and still exists in some European 
countries today (Einstein, 2007).  Other substances, such as ecstasy/MDMA, which have known 
medicinal and therapeutic effects, may require a prescription from a licenced psychotherapist 
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(Wodak, 2014). Substances traditionally used in spiritual or religious rituals and ceremonies, 
such as psilocybin mushrooms and ayahuasca, may require a licence to distribute within a 
controlled environment. While some substances may be sold in stores, as is the case with 
cannabis in some North American locations, others may be dispensed by pharmacists, and others 
in licenced establishments, much like bars (Toine, 2012).  
 Regulating the drug market is clearly not as simple as providing uniformly unrestricted 
access to all currently illicit substances.  The suggestions provided above are intended to 
illustrate the complexities of creating a comprehensive regulatory framework, and demonstrate 
the need for a variety of approaches for regulating a variety of substances. Whatever the case, 
legalization and regulation of drugs must primarily take a public health approach that has been 
lacking under prohibition (Mostyn et al., 2012; Toine, 2012; Wodak, 2014). In doing so, funding 
previously used for the enforcement of drug laws may be funneled into initiatives to reduce the 
harms of drug use on individuals and communities (Toine, 2012). Future research on drug policy 
reform must work to formulate innovative regulatory frameworks that may do so.  
A Vehicle for Change: Social Movement Mobilization  
The scientific data regarding the value of harm reduction programming and the 
detriments of drug prohibition has been available to policy-makers and the general public for 
decades. However, change is slow to occur, and no talks of decriminalization or legalization are 
in the works in Canada, with the exception of the recent legalization of cannabis. Harm reduction 
philosophies are still considered to be a controversial subject, and programs remain scarcely 
funded. In order to effect real change at the policy level, more than just empirical evidence is 
needed. Harm reduction programs emerged first from the advocacy work of people who inject 
drugs, and gained footing through subsequent grassroots movements (Drucker, 2013). It was by 
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processes of advocacy and social mobilization that harm reduction philosophies have become 
normative in service provision. It is by these same processes that drug policies may be reformed 
and aligned with harm reduction philosophies. 
Harm reduction is principally about the empowerment of individuals who use drugs and 
the amelioration of the stigma they face. Therefore, attempting to enact policy change based on 
empirical research that excludes their voices goes against the very foundation on which harm 
reduction rests (Campbell & Shaw, 2008; McCann & Temenos, 2015). Social movements must 
allow for the leadership of the individuals primarily impacted by current drug policies.  
Currently, much leadership within harm reduction movements are “middle class workers”, such 
as social workers and nurses (Friedman et al., 2001). As harm reduction programming becomes 
increasingly coopted by professional service providers with no lived experience of the harms of 
drug use and repressive drug policies, we see limitations in these programs abilities to fulfill their 
potential. Similarly, this appropriating of the harm reduction movement and exclusion of people 
who use drugs will subsequently result in the professionalization of advocacy, and thus, these 
movements will fall short (Eversman, 2014). In addition to including people who use drugs and 
the working class in these movements, it is of exceptional importance that Black and Indigenous 
leadership be respected, as these communities are disproportionately impacted by the 
consequences of repressive drug policies.  If drug policy reform movements are expected to be 
successful in addressing the harms of prohibitory drug policies, they must acknowledge the 
historical context of these policies, and the ethnocentrism and classism involved in their 
continued enforcement. By including and respecting the leadership of people with lived 
experience, social movements can begin to reverse the stigma faced by people who use drugs as 
a result of their deviant and criminal labels. Research on social movements in their application to 
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drug policy reform is limited, and future work on mobilizing these movements should seek 
direction from individuals and communities most impacted by drug prohibition. 
Conclusion 
 Through social constructionist lens we have understood prohibitory drug policies as 
historically serving the purpose of casting deviant identities on already impoverished and 
racialized individuals who use drugs. By labelling those who use drugs as deviants, these policies 
create a morality of health via criminalizing marginalized communities. This criminalization 
results in stigmatization and thus impedes the delivery of potentially life-saving harm reduction 
programming. By prioritizing these programs, and aligning overarching drug policies with harm 
reduction philosophies, the harms of zero-tolerance drug policies and drug use may be alleviated.  
By extension, the harms of the enforcement and stigmatization associated with drug prohibition, 
in addition to the professionalization of service provision, may be addressed, in addition to 
alleviating the detriments of interacting with illegal drug markets and criminal justice systems. 
Considering the public good, and individual autonomy and liberty leads to the seeking out of 
frameworks by which crimes of morality have been policed around the globe. This allows for an 
assessment of the Portuguese Model of decriminalization of drug use and other alternative 
regulatory frameworks as best practices for minimizing the consequences of drug use on 
individuals and the greater community. In recommending these policy reforms, a discussion 
regarding the means for achieving legislative restructuring is necessary. Future research on drug 
policy reform must both work to formulate innovative frameworks for addressing substance use 
from a public health approach, and investigate approaches for social mobilization and advocacy 
work to achieve reforms.  As the criminalization of drug use continues to result in the labelling 
and subsequent stigmatization of people who use drugs, it cannot exist alongside harm reduction 
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programming without impeding its provision. Therefore, drug policies must align with harm 
reduction philosophies in order to alleviate the harms of drug use, current drug policies, and the 
stigmatization of the drug using population.  
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